Federal Register - July 22, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
38624
Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Proposed Rules
relationship between the national government and the States, or the distribution of power and responsibilities among the various levels of government.
Executive Order 13175, Consultation and Coordination With Indian Tribal Governments This proposed rule does not have tribal implications warranting the application of E.O. 13175. It does not have substantial direct effects on one or more Indian tribes, on the relationship between the Federal government and Indian tribes, or on the distribution of power and responsibilities between the Federal government and Indian tribes.
Paperwork Reduction Act of 1995
This action does not impose a new collection of information requirement under the Paperwork Reduction Act of 1995 44 U.S.C. 35013521.
Regulatory Flexibility Act The Administrator of DEA, in accordance with the Regulatory Flexibility Act, 5 U.S.C. 601612, has reviewed this proposed rule and, by approving it, certifies that it will not have a significant economic impact on a substantial number of small entities.
DEA proposes placing the substance amineptine, including its isomers, salts, and salts of isomers, in schedule I of the CSA. This action is being taken to enable the United States to meet its obligations under the 1971 Convention.
If finalized, this action would impose the regulatory controls and administrative, civil, and/or criminal sanctions applicable to schedule I
controlled substances on persons who handle manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess, or propose to handle, amineptine.
According to HHS, amineptine has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and lacks accepted safety for use under medical supervision. DEAs research confirms that there is no commercial market for amineptine in the United States.
Additionally, queries of DEAs STRIDE/
STARLiMS and the NFLIS databases on November 17, 2020, did not generate any reports of amineptine, suggesting that it is not trafficked in the United States. Therefore, DEA estimates that no United States entity currently handles amineptine and does not expect any United States entity to handle amineptine in the foreseeable future.
DEA concludes that no United States entity would be affected by this rule, if finalized. As such, the proposed rule will not have a significant effect on a substantial number of small entities.
Unfunded Mandates Reform Act of 1995
On the basis of information contained in the Regulatory Flexibility Act section above, DEA has determined
pursuant to the Unfunded Mandates Reform Act UMRA of 1995 2 U.S.C.
1501 et seq. that this action would not result in any Federal mandate that may result in the expenditure by State, local, and tribal governments, in the aggregate, or by the private sector, of $100,000,000 or more adjusted annually for inflation in any 1 year . Therefore, neither a Small Government Agency Plan nor any other action is required under provisions of the UMRA of 1995.
List of Subjects in 21 CFR Part 1308
Administrative practice and procedure, Drug traffic control, Reporting and recordkeeping requirements.
For the reasons set out above, 21 CFR
part 1308 is proposed to be amended to read as follows:
PART 1308SCHEDULES OF
CONTROLLED SUBSTANCES
1. The authority citation for 21 CFR
part 1308 continues to read as follows:
Authority: 21 U.S.C. 811, 812, 871b, 956b, unless otherwise noted.
2. Amend 1308.11 by re-designating paragraphs f1 through f9 as paragraphs f2 through f10, and adding a new paragraph f1 to read as follows:
1308.11
Schedule I.
f
1 Amineptine 7-10,11-dihydro-5H-dibenzoa,dcyclohepten-5-ylaminoheptanoic acid
Anne Milgram, Administrator.
FR Doc. 202115331 Filed 72121; 8:45 am BILLING CODE 441009P
DEPARTMENT OF JUSTICE
28 CFR Part 16
CPCLO Order No. 0032021
Privacy Act of 1974; Implementation United States Department of Justice.
ACTION: Notice of proposed rulemaking.
lotter on DSK11XQN23PROD with PROPOSALS1
AGENCY:
On July 14, 2021 in the publication of the Federal Register at 86
FR 37188, the Department of Justice Department or DOJ, has published a notice of a modified system of records that was retitled as, Department of Justice Information Technology,
SUMMARY:
VerDate Sep<11>2014
16:30 Jul 21, 2021
Jkt 253001
Information System, and Network Activity and Access Records, JUSTICE/
DOJ002. In this notice of proposed rulemaking, DOJ proposes to exempt this system of records from certain provisions of the Privacy Act in order to avoid interference with the efforts of DOJ and others to prevent the unauthorized access, use, disclosure, disruption, modification, or destruction of DOJ information and information systems, and to protect information on DOJ classified networks. For the reasons provided below, the Department proposes to amend its Privacy Act regulations by establishing an exemption for records in this system from certain provisions of the Privacy Act. Public comment is invited.
DATES: Comments must be received by August 23, 2021.
ADDRESSES: You may send comments by any of the following methods:
Federal eRulemaking Portal: http
www.regulations.gov. When submitting
PO 00000
Frm 00035
Fmt 4702
Sfmt 4702
1219
comments electronically, you must include the CPCLO Order No. in the subject box. Please note that the Department is requesting that electronic comments be submitted before midnight Eastern Standard Time on the day the comment period closes because http
www.regulations.gov terminates the publics ability to submit comments at that time. Commenters in time zones other than Eastern Standard Time may want to consider this so that their electronic comments are received.
Mail: United States Department of Justice, Office of Privacy and Civil Liberties, ATTN: Privacy Analyst, Office of Privacy and Civil Liberties, 145 N St.
NE, Suite 8W.300, Washington, DC
20530. All comments sent via regular or express mail will be considered timely if postmarked on the day the comment period closes. To ensure proper handling, please reference the CPCLO
Order No. in your correspondence.
Posting of Public Comments:
Interested persons are invited to
E:FRFM22JYP1.SGM
22JYP1